EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

GP-Act III Acquisition Corp. Class A (GPAT) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of GP-Act III Acquisition Corp. Class A $11.50, price $10.99, upside +4.6%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Financial Services · US · ISIN KYG4035N1034

GA GP-Act III Acquisition Corp. Class A logo Thin data Sep 24, 2026

GP-Act III Acquisition Corp. Class A

GPAT · US

NeutralThe stock looks roughly fairly valued with average quality.

·Fair value $11.50 · Fairly valued (+5%)
!Quality 56/100
!negative free cash flow
✓Ranks above peers (7/8)
!Narrow moat 26/100
!Evidence only low, so the estimate is less certain
Watch GP-Act III Acquisition Corp. Class A Ordinary Share for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$11.16 $9.98 Fair Value $11.50 Jul 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

27‑month range $9.98 – $11.16 · fair‑value band $7.17 – $11.96 · the $10.99 price screens below the $11.50 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow GP-Act III Acquisition Corp. Class A Ordinary Share in your weekly email

Every Wednesday you see whether GP-Act III Acquisition Corp. Class A Ordinary Share is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp.

Show more

GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. was incorporated in 2020 and is based in New York, New York.

Stock analysis

GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT) currently trades at $10.99, while our model-based Fair Value estimate is $11.50, implying the stock looks roughly 4.4% fairly valued today.

Show more

Valuation

Bull case: the Asset-Based group reads highest at a median of $12.22 per share, and 4 of the 6 models we run sit above the $10.99 price.

Bear case: the Earnings-Based group reads lowest at $3.68, and 2 of the 6 models stay below the price. Evidence for this calculation is low.

Scenario range: $7.17 (bear) to $11.96 (bull), the price of $10.99 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 56/100 (solid quality), in the Financial Services sector.

GP-Act III Acquisition Corp. Class A Ordinary Share reported revenue of $0 in FY2025 versus $0 in FY2022. Reported net income was $11.9M in FY2025.

Key figures

Market cap $251M · P/E ratio 44.0 · EPS (TTM) $0.2500 · Return on equity 9.8% · Return on assets (EBIT) −1.5% · EPS growth (YoY) −86.2% · Free cash flow −$372K · Net debt $287K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 24 out of 100 (low confidence).

What moves the price

The share trades about 2% below its 52-week high and 4% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −53% fair-value upside, at 5%, GPAT screens cheaper than that median.

Fair Value models

Bear $7.17 Fair Value $11.50 Bull $11.96
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.1829 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
P/E Multiple $7.17 $9.57 $11.96 63
Residual Income $12.21 $11.61 $9.12 61
P/B Multiple $9.38 $12.51 $15.64 55
All 6 models by family
Earnings-Based
Graham-Dodd $5.00 $13.31 $17.40 51
Lynch FV $2.58 $3.68 $4.78 48
Multiples
P/E Multiple $7.17 $9.57 $11.96 63
P/B Multiple $9.38 $12.51 $15.64 55
Asset-Based
NCAV (Graham) $9.12 $12.22 $18.23 51
Economic Profit
Residual Income $12.21 $11.61 $9.12 61

Open the full fair value analysis →

Notify me when GPAT reaches fair value

Put GPAT on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 56/100

Of which business quality 60 · Market factors (momentum, volatility) 63

Profitability 21
Margins and returns on capital today
Quality Growth 55
Are margins and returns improving?
Cashflow 100
Earnings quality: real cash, not paper profit
Fin. Strength 67
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 43
Price trend over the last 3–12 months (market factor)
52W Momentum 54
Distance to the 52-week high (market factor)
Net Issuance 100
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Watch GPAT, get fair value alerts →

Compare GP-Act III Acquisition Corp. Class A Ordinary Share with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 80 stocks

Beats the industry median on 7/8 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 54 · Above median
Fair Value upside +5% · Top 25%
Profitability
Return on equity (TTM) 10% · Top 25%
Return on assets −1% · Above median
Operating margin (TTM) 0% · Top 25%
Growth and dividend
Revenue growth 0% · Top 25%

Valuation Multiplesvs Shell Companies median · lower = cheaper

P/E (TTM) 44.0× · Pricier than median
P/B 0.85× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)39 · sector 21
FUTURE (revenue growth)0 · sector 0
PAST (return on equity)39 · sector 0
HEALTH (low debt)0 · sector 99
DIVIDEND (yield)0 · sector 0

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Shell Companies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Lionheart III Corp LION $11.36 $15.02 +32%
AA Mission Acquisition Corp AAM $0.0360 $0.0490 +36%
Berto Acquisition Corp TACO $10.46 $2.73 −74%
Metals Acquisition Corp MTAL $10.16 $20.32 +100%
Axiom Intelligence Acquisition Corp AXIN $10.33 $1.71 −83%
Bold Eagle Acquisition Corp BEAG $10.82 $4.00 −63%
Lionheart Holdings CUB $10.88 $5.06 −53%
Texas Ventures Acquisition III Corp TVACW $0.2210 $0.2600 +18%
Translational Development Acquisition Corp TDAC $10.86 $4.28 −61%
TGE Value Creative Solutions Corp BEBE $10.04 $3.58 −64%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

GP-Act III Acquisition Corp. Class A Ordinary Share · Fair Value
$11.50 +4%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "GP-Act III Acquisition Corp. Class A Ordinary Share Fair Value". https://www.fairvalue-calculator.com/stock/GPAT

Frequently asked questions

Is GP-Act III Acquisition Corp. Class A (GPAT) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $11.50 versus a price of $10.99, about +5% upside (fairly valued).
What is the fair value of GPAT?
Our model-based fair value for GP-Act III Acquisition Corp. Class A Ordinary Share is $11.50 (as of Sep 24, 2026), built from audited fundamentals. The current price: $10.99.
What is the quality score of GPAT?
GP-Act III Acquisition Corp. Class A Ordinary Share has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for GP-Act III Acquisition Corp. Class A (GPAT)?
Our model-based price target is the fair value of $11.50 (as of Sep 24, 2026) from 6 valuation models. Cautious scenario $7.17, optimistic scenario $11.96. It is a calculation from audited fundamentals, not an analyst target.
What is the GP-Act III Acquisition Corp. Class A Ordinary Share stock forecast for 2026?
Our models put fair value at $11.50, about +5% upside versus a price of $10.99 (fairly valued). Cautious scenario $7.17, optimistic scenario $11.96. The calculation is refreshed regularly with new filings.
What is the intrinsic value of GP-Act III Acquisition Corp. Class A (GPAT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For GP-Act III Acquisition Corp. Class A Ordinary Share it is $11.50 per share (as of Sep 24, 2026), against a price of $10.99. It is the blended result of 6 valuation models (cash flow, earnings, asset, dividend).
Is GP-Act III Acquisition Corp. Class A Ordinary Share stock overvalued or undervalued in 2026?
As of Sep 24, 2026, GPAT trades below its calculated fair value: price $10.99, fair value $11.50, a gap of about +5% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GPAT?
No. The price is what the market pays today ($10.99); the fair value is what the company's own numbers justify ($11.50). For GP-Act III Acquisition Corp. Class A Ordinary Share the two are $0.5100 per share apart. That gap is exactly why we show both numbers side by side.
How much is GP-Act III Acquisition Corp. Class A Ordinary Share worth?
The market values GP-Act III Acquisition Corp. Class A Ordinary Share at about $251M (market capitalisation, as of Sep 24, 2026). Per share that is $10.99; our models calculate a fair value of $11.50 per share.
What do the bullish and bearish scenarios say about GPAT?
Our models span a range for GP-Act III Acquisition Corp. Class A Ordinary Share: cautious scenario $7.17, base $11.50, optimistic $11.96 per share (as of Sep 24, 2026, price $10.99). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GPAT?
GP-Act III Acquisition Corp. Class A Ordinary Share trades at a price-to-earnings ratio of 44.0 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $11.50 is built from several models across several years. Other multiples: P/B 0.9.
How solid is the balance sheet of GP-Act III Acquisition Corp. Class A (GPAT)?
Balance-sheet figures for GP-Act III Acquisition Corp. Class A Ordinary Share (as of Sep 24, 2026): return on equity 9.8%. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is GPAT from its 52-week high?
GP-Act III Acquisition Corp. Class A Ordinary Share trades at $10.99, about 2% below its 52-week high of $11.16 and 4% above the low of $10.58 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $11.50 is for.
Which stocks are comparable to GP-Act III Acquisition Corp. Class A Ordinary Share?
From the same area (Financial Services) we also value Lionheart III Corp, AA Mission Acquisition Corp, Berto Acquisition Corp, Metals Acquisition Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is GP-Act III Acquisition Corp. Class A Ordinary Share stock attractive at the current price?
The data as of Sep 24, 2026: price $10.99, calculated fair value $11.50 (+5%), Quality Score 56/100, from 6 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GPAT calculated?
We run GP-Act III Acquisition Corp. Class A Ordinary Share through 6 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $11.50, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. GP-Act III Acquisition Corp. Class A Ordinary Share currently trades 5 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of GP-Act III Acquisition Corp. Class A (GPAT)?
The closing price on Sep 23, 2026 was $10.99. Our model-based fair value is $11.50, about +5% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with GP-Act III Acquisition Corp. Class A Ordinary Share right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of GP-Act III Acquisition Corp. Class A Ordinary Share

How large is the market capitalisation of GP-Act III Acquisition Corp. Class A (GPAT)?
The market capitalisation of GP-Act III Acquisition Corp. Class A Ordinary Share is $251M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of GP-Act III Acquisition Corp. Class A (GPAT)?
Earnings per share at GP-Act III Acquisition Corp. Class A Ordinary Share are $0.2500 (price ÷ EPS = P/E 44.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of GP-Act III Acquisition Corp. Class A (GPAT)?
The return on equity (ROE) of GP-Act III Acquisition Corp. Class A Ordinary Share is 9.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of GP-Act III Acquisition Corp. Class A (GPAT)?
On an EBIT basis the return on assets of GP-Act III Acquisition Corp. Class A Ordinary Share is −1.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How fast are earnings growing at GP-Act III Acquisition Corp. Class A (GPAT)?
Earnings per share at GP-Act III Acquisition Corp. Class A Ordinary Share are growing −86.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does GP-Act III Acquisition Corp. Class A (GPAT) generate?
The free cash flow of GP-Act III Acquisition Corp. Class A Ordinary Share is −$372K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does GP-Act III Acquisition Corp. Class A (GPAT) carry?
The net debt of GP-Act III Acquisition Corp. Class A Ordinary Share is $287K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch GP-Act III Acquisition Corp. Class A Ordinary Share in the live analysis

One click puts GP-Act III Acquisition Corp. Class A Ordinary Share on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.